UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934
(Amendment No. 19)

Evolving Systems, Inc.

(Name of Issuer)

Common Stock

30049R209

Karen Singer
212 Vaccaro Drive
Cresskill, NJ 07626
(201) 750-0415
of Person Authorized to Receive Notices
and Communications)

July 15. 2011

     If the filing person has previously filed a statement on Schedule 13G to report this acquisition that is the subject of this Schedule 13D, and is filing this Schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box: o

     *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

 

 

			SCHEDULE 13D/A19
CUSIP No.		30049R209

     This constitutes Amendment No. 19 (the “Amendment No. 19”) to the Statement on Schedule 13D, filed on behalf of Karen Singer (“Ms. Singer”), dated February 28, 2008 (the “Statement”), relating to the common stock (the “Common Stock”) of Evolving Systems, Inc., a Delaware corporation (the “Issuer” or “Company”). Unless specifically amended or modified hereby, the disclosure set forth in the Statement shall remain unchanged.

Item 4.		Purpose of the Transaction.

Item 4 of the Statement is hereby amended and restated in its entirety as follows:

     As stated in the Issuer’s Current Report on Form 8-K filed by the Issuer on April 21, 2011, the Issuer has entered into a definitive agreement to sell its Numbering Solutions business to Neustar, Inc. for $39.0 million in cash and the assumption of certain liabilities. As a holder of approximately 23% of the shares of common stock of Evolving Systems, the Trust intends to vote in favor of the proposed transaction.

     As previously disclosed, on November 26, 2010, Ms. Singer entered into a Confidentiality Agreement, in the form previously filed as Exhibit 99.1 to Schedule 13D (the “Confidentiality Agreement”), between the Issuer and Ms. Singer. The Confidentiality Agreement provided that, subject to certain exceptions set forth therein, the Trust would keep confidential certain information received by the Trust from the Issuer. As disclosed previously, Ms. Singer entered into the Confidentiality Agreement in connection with the Trust’s ongoing discussions with the Company regarding governance and enhancing shareholder value. The term of the Confidentiality Agreement was extended several times and, effective April 22, 2011, the Confidentiality Agreement was amended to extend further the period during which it remained effective so that, as so amended, the Confidentiality Agreement remained in effect until June 30, 2011. Effective July 15, 2011, the Confidentiality Agreement was reinstated and, as so reinstated, the Confidentiality Agreement was further amended to extend the period during which it remains effective until August 15, 2011.

     Except as described above in this Item 4 and herein, Ms. Singer does not currently have any specific plans or proposals that relate to or would result in any of the actions or events specified in clauses (a) through (j) of Item 4 of Schedule 13D. Ms. Singer reserves the right to change plans and take any and all actions that Ms. Singer may deem appropriate to maximize the value of her investments, including, among other things, purchasing or otherwise acquiring additional securities of the Issuer, selling or otherwise disposing of any securities of the Issuer beneficially owned by her, in each case in the open market or in privately negotiated transactions, or formulating other plans or proposals regarding the Issuer or its securities to the extent deemed advisable by Ms. Singer in light of her general investment policies, market conditions, subsequent developments affecting the Issuer and the general business and future prospects of the Issuer. Ms. Singer may take any other action with respect to the Issuer or any of the Issuer’s debt or equity securities in any manner permitted by applicable law.

Item 6.		Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer

     Item 4 of this Schedule 13D/A is incorporated herein by reference.

Item 7. Material to be Filed as Exhibits

     Exhibit 99.1 Amendment to Confidentiality Agreement dated July 15, 2011.

SIGNATURES

     After reasonable inquiry and to the best of the undersigned’s knowledge and belief, the undersigned hereby certifies that the information set forth in this statement is true, complete and correct.

Dated: July 18, 2011